EvoNext Holdings S.A.
0QQJ.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.94M
Close$
$0.78
67.5% downside
Current Fair Value
67.5% downsideOvervalued by 67.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $15.94 Million |
|---|---|
| Enterprise Value | $11.72 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.09 |
| Beta | -0.05 |
| Outstanding Shares | 7,211,552 |
Return
| Return on Equity | -33.49% |
|---|---|
| Return on Assets | -31.90% |
| Return on Invested Capital | -29.74% |
Valuation & Multiples
| P/E Ratio | -17.04 |
|---|---|
| PEG | -22.47 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.42 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
February 19, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About EvoNext Holdings S.A.
49 employees
CEO: Gerhard Lobmaier EvoNext Holdings SA specializes in the discovery, refinement, and distribution of cutting-edge components for the nutrition, health, and well-being industries. The enterprise was co-founded in 2004 by Alexandra Santana Sørensen, Søren V....